(ACAD) ACADIA Pharmaceuticals - Performance -1.2% in 12m
Compare ACAD with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
-52.28%
#77 in Group
Rel. Strength
31.45%
#5455 in Universe
Total Return 12m
-1.17%
#59 in Group
Total Return 5y
-66.73%
#73 in Group
P/E 11.1
38th Percentile in Group
P/E Forward 24.5
81th Percentile in Group
PEG -0.42
26th Percentile in Group
FCF Yield 8.63%
86th Percentile in Group
12m Total Return: ACAD (-1.2%) vs XBI (-12.3%)

5y Drawdown (Underwater) Chart

Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
UTHR NASDAQ United Therapeutics |
10.1% | 18% | 166% | 12.1 | 11 | 1.43 | 74.6% | 16.1% |
HLN NYSE Haleon |
14.3% | 31.2% | 47% | 24.4 | 20.2 | 1.79 | 69.1% | 13.6% |
AMGN NASDAQ Amgen |
-2.93% | -8.78% | 30.7% | 25.5 | 13.5 | 0.95 | 0.60% | 41% |
LONN SW Lonza |
9.55% | 9.34% | 30.4% | 67.1 | 35.1 | 1.28 | 2.20% | -12.5% |
BIM PA Biomerieux |
0.78% | 17.8% | -2.14% | 32.5 | 25.2 | 1.52 | -38.5% | -25.1% |
KMDA NASDAQ Kamada |
21.4% | 25.3% | -4.13% | 26.6 | 23.9 | 0.96 | 32.5% | 3.93% |
NBIX NASDAQ Neurocrine Biosciences |
34.3% | -15.5% | 3.48% | 32.3 | 21.6 | 0.27 | 68.0% | 31.9% |
ERF PA Eurofins Scientific SE |
20.4% | -0.39% | 7.63% | 26.6 | 13.6 | 0.56 | -66.6% | -17.1% |
Performance Comparison: ACAD vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for ACAD
Total Return (including Dividends) | ACAD | XBI | S&P 500 |
---|---|---|---|
1 Month | 20.07% | 11.81% | 13.81% |
3 Months | -10.33% | -13.61% | -6.30% |
12 Months | -1.17% | -12.29% | 10.65% |
5 Years | -66.73% | -24.89% | 107.77% |
Trend Score (consistency of price movement) | ACAD | XBI | S&P 500 |
1 Month | 19.3% | 72.9% | 83% |
3 Months | -89.7% | -83% | -75.3% |
12 Months | 18.7% | -51.6% | 50.1% |
5 Years | -57.9% | -53.9% | 84.1% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
1 Month | #167 | 7.39% | 5.50% |
3 Month | #106 | 3.80% | -4.30% |
12 Month | #59 | 12.7% | -10.7% |
5 Years | #77 | -55.7% | -84.0% |
FAQs
Does ACAD ACADIA Pharmaceuticals outperforms the market?
Yes,
over the last 12 months ACAD made -1.17%, while its related Sector, the SPDR S&P Biotech (XBI) made -12.29%.
Over the last 3 months ACAD made -10.33%, while XBI made -13.61%.
Over the last 3 months ACAD made -10.33%, while XBI made -13.61%.
Performance Comparison ACAD vs Indeces and Sectors
ACAD vs. Indices ACAD is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | 15.0% | 6.26% | 0.81% | -11.8% |
US NASDAQ 100 | QQQ | 14.8% | 2.71% | 0.60% | -12.8% |
US Dow Jones Industrial 30 | DIA | 14.6% | 10.1% | 1.10% | -8.88% |
German DAX 40 | DAX | 15.0% | 5.11% | -25.5% | -26.9% |
Shanghai Shenzhen CSI 300 | CSI 300 | 12.8% | 8.24% | 0.04% | -8.54% |
Hongkong Hang Seng | HSI | 11.9% | 0.14% | -7.55% | -14.9% |
India NIFTY 50 | INDA | 19.9% | 15.2% | 0.37% | -0.96% |
Brasil Bovespa | EWZ | 14.0% | 2.83% | -7.89% | 7.16% |
ACAD vs. Sectors ACAD is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | 14.4% | 6.66% | -6.25% | -22.7% |
Consumer Discretionary | XLY | 14.6% | 5.84% | 1.79% | -15.4% |
Consumer Staples | XLP | 15.9% | 13.5% | -6.12% | -10.3% |
Energy | XLE | 15.2% | 13.3% | 7.40% | 8.29% |
Financial | XLF | 13.9% | 6.55% | -6.29% | -23.6% |
Health Care | XLV | 18.0% | 19.2% | 5.80% | 2.89% |
Industrial | XLI | 13.3% | 3.25% | -0.62% | -12.2% |
Materials | XLB | 15.2% | 6.51% | 5.70% | 4.06% |
Real Estate | XLRE | 16.3% | 8.53% | 0.06% | -16.6% |
Technology | XLK | 13.9% | -1.15% | 3.69% | -8.27% |
Utilities | XLU | 15.0% | 10.5% | -6.85% | -18.6% |
Aerospace & Defense | XAR | 13.0% | -1.09% | -10.7% | -28.5% |
Biotech | XBI | 21.6% | 8.26% | 21.0% | 11.1% |
Homebuilder | XHB | 14.6% | 8.59% | 14.0% | 6.38% |
Retail | XRT | 13.1% | 5.42% | 5.05% | 0.31% |